News

Kennedy's new US vaccine panel to discuss measles shot for children
U.S. vaccine advisers will discuss recommendations for flu vaccines containing the preservative thimerosal and a combination ...
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
CDC vaccine advisers to vote on thimerosal in flu shots at first meeting of new panel
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
RFK Jr.’s new vaccine advisers to discuss preservative wrongly linked to autism
A key vaccine advisory panel handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. is set to vote on a vaccine ingredient wrongly linked to autism as part of its scaled-down ...
FDA approves the world’s only twice-a-year shot to prevent HIV
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...
FDA Approves a Twice-Yearly Shot to Prevent HIV
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The Kenya Times on MSN3h
Breakthrough as FDA Approves New HIV Prevention Injection
The US Food and Drug Administration (FDA) has approved Gilead Sciences’ Yeztug (lenacapavir), an injectable HIV-1 capsid inhibitor, for use as pre-exposure prophylaxis (PrEP) to reduce the risk of ...